Literature DB >> 26854154

In Vivo Phenotyping of Tumor Metabolism in a Canine Cancer Patient with Simultaneous (18)F-FDG-PET and Hyperpolarized (13)C-Pyruvate Magnetic Resonance Spectroscopic Imaging (hyperPET): Mismatch Demonstrates that FDG may not Always Reflect the Warburg Effect.

Henrik Gutte1, Adam E Hansen2, Majbrit M E Larsen3, Sofie Rahbek4, Helle H Johannesen5, Jan Ardenkjaer-Larsen6,7, Annemarie T Kristensen8, Liselotte Højgaard9, Andreas Kjaer10.   

Abstract

In this communication the mismatch between simultaneous (18)F-FDG-PET and a (13)C-lactate imaging (hyperPET) in a biopsy verified squamous cell carcinoma in the right tonsil of a canine cancer patient is shown. The results demonstrate that (18)F-FDG-PET may not always reflect the Warburg effect in all tumors.

Entities:  

Keywords:  13C-pyruvate; 18F-FDG-PET; MR; PET/MR; cancer; dynamic nuclear polarization; hyperPET; hyperpolarized; molecular imaging

Year:  2015        PMID: 26854154      PMCID: PMC4665599          DOI: 10.3390/diagnostics5030287

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


HyperPET is a new in vivo imaging modality that consists of combining a PET scan with magnetic resonance spectroscopic imaging (MRSI) of hyperpolarized 13C-pyruvate made possible by integrated hybrid PET/MRI systems [1]. The metabolism of cancer cells is characterized by a shift to glycolysis with production of lactate even in the presence of sufficient oxygen, this phenomenon is also known as the Warburg effect [2,3,4]. With the introduction of hyperpolarized 13C-pyruvate/13C-lactate MRSI it is probably now possible to directly study the metabolism of lactate and Warburg effect in real time. This is opposed to imaging with 18F-FDG PET scan alone, which demonstrates the Warburg effect only indirectly through increased glucose utilization and uptake. In Figure 1, 18F-FDG-PET and 13C-lactate MRSI in a spontaneous canine tumor is shown. A clear mismatch between 18F-FDG uptake and 13C-lactate production is seen. In an axial slice of the neck in a canine cancer patient with a biopsy verified squamous cell carcinoma in the right tonsil, we noticed in panel A clear discrepancy between the 18F-FDG-PET (18F-FDG activity is shown in grey scale and the dashed arrow points at the margin of tumor) and the 13C-lactate production (red to yellow color corresponds to the 13C-Lactate production and the arrow points to the margin of tumor) in a large heterogeneous tumor. 18F-FDG uptake in the tumor was variable in the tumor (panel C) and corresponded to the anatomical MR images in that high 18F-FDG levels paralleled the uptake of Gadolinium in the T1 sequence (panel B, dashed line outlines the contour of the tumor). However 13C-lactate did not correspond to the 18F-FDG uptake, especially in the more profound region of the tumor where we demonstrated a large production of 13C-lactate indicating higher degree of glycolysis (panel D). The Ethics and Administrative Committee, Department of Veterinary Clinical and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen approved the study. Whereas 18F-FDG-PET has generally been accepted as an indicator of the Warburg effect the hyperPET imaging of a canine tumor demonstrates that this may not always be the case. Accordingly, the new technique of hyperPET that we recently introduced can expose such diversity in metabolism. We suggest that hyperPET may become a valuable tool for better phenotyping of tumors to be used for prognostication, treatment planning and response monitoring.
Figure 1

HyperPET is a new in vivo imaging modality that consists of combining a PET scan with magnetic resonance spectroscopic imaging (MRSI) of hyperpolarized 13C-pyruvate made possible by integrated hybrid PET/MRI systems [1]. The metabolism of cancer cells is characterized by a shift to glycolysis with production of lactate even in the presence of sufficient oxygen, this phenomenon is also known as the Warburg effect [2,3,4]. With the introduction of hyperpolarized 13C-pyruvate/13C-lactate MRSI it is probably now possible to directly study the metabolism of lactate and Warburg effect in real time. This is opposed to imaging with 18F-FDG PET scan alone, which demonstrates the Warburg effect only indirectly through increased glucose utilization and uptake. In Figure 1, 18F-FDG-PET and 13C-lactate MRSI in a spontaneous canine tumor is shown. A clear mismatch between 18F-FDG uptake and 13C-lactate production is seen. In an axial slice of the neck in a canine cancer patient with a biopsy verified squamous cell carcinoma in the right tonsil, we noticed in panel A clear discrepancy between the 18F-FDG-PET (18F-FDG activity is shown in grey scale and the dashed arrow points at the margin of tumor) and the 13C-lactate production (red to yellow color corresponds to the 13C-Lactate production and the arrow points to the margin of tumor) in a large heterogeneous tumor. 18F-FDG uptake in the tumor was variable in the tumor (panel C) and corresponded to the anatomical MR images in that high 18F-FDG levels paralleled the uptake of Gadolinium in the T1 sequence (panel B, dashed line outlines the contour of the tumor). However 13C-lactate did not correspond to the 18F-FDG uptake, especially in the more profound region of the tumor where we demonstrated a large production of 13C-lactate indicating higher degree of glycolysis (panel D). The Ethics and Administrative Committee, Department of Veterinary Clinical and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen approved the study. Whereas 18F-FDG-PET has generally been accepted as an indicator of the Warburg effect the hyperPET imaging of a canine tumor demonstrates that this may not always be the case. Accordingly, the new technique of hyperPET that we recently introduced can expose such diversity in metabolism. We suggest that hyperPET may become a valuable tool for better phenotyping of tumors to be used for prognostication, treatment planning and response monitoring.

  4 in total

1.  Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner.

Authors:  Henrik Gutte; Adam E Hansen; Sarah T Henriksen; Helle H Johannesen; Jan Ardenkjaer-Larsen; Alexandre Vignaud; Anders E Hansen; Betina Børresen; Thomas L Klausen; Anne-Mette N Wittekind; Nic Gillings; Annemarie T Kristensen; Andreas Clemmensen; Liselotte Højgaard; Andreas Kjær
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

Review 2.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

3.  [18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice.

Authors:  Mette Munk Jensen; Kamille Dumong Erichsen; Camilla Bardram Johnbeck; Fredrik Björkling; Jacob Madsen; Peter Buhl Jensen; Maxwell Sehested; Liselotte Højgaard; Andreas Kjær
Journal:  BMC Cancer       Date:  2013-04-01       Impact factor: 4.430

4.  18F-FDG and 18F-FLT-PET imaging for monitoring everolimus effect on tumor-growth in neuroendocrine tumors: studies in human tumor xenografts in mice.

Authors:  Camilla Bardram Johnbeck; Mette Munk Jensen; Carsten Haagen Nielsen; Anne Mette Fisker Hag; Ulrich Knigge; Andreas Kjaer
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  4 in total
  5 in total

Review 1.  Probing carbohydrate metabolism using hyperpolarized 13 C-labeled molecules.

Authors:  Jaspal Singh; Eul Hyun Suh; Gaurav Sharma; Chalermchai Khemtong; A Dean Sherry; Zoltan Kovacs
Journal:  NMR Biomed       Date:  2018-11-26       Impact factor: 4.044

Review 2.  Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.

Authors:  Fulvio Zaccagna; James T Grist; Surrin S Deen; Ramona Woitek; Laura Mt Lechermann; Mary A McLean; Bristi Basu; Ferdia A Gallagher
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

3.  Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.

Authors:  Inés Sáenz-de-Santa-María; Cristóbal Bernardo-Castiñeira; Pablo Secades; Sandra Bernaldo-de-Quirós; Juan Pablo Rodrigo; Aurora Astudillo; María-Dolores Chiara
Journal:  Oncotarget       Date:  2017-02-21

4.  Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG.

Authors:  Benedikt Feuerecker; Michael Michalik; Christian Hundshammer; Markus Schwaiger; Frank Bruchertseifer; Alfred Morgenstern; Christof Seidl
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

5.  [68Ga]Ga-NODAGA-E[(cRGDyK)]2 PET and hyperpolarized [1-13C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect.

Authors:  Andreas Clemmensen; Adam E Hansen; Pernille Holst; Christina Schøier; Sissel Bisgaard; Helle H Johannesen; Jan Henrik Ardenkjær-Larsen; Annemarie T Kristensen; Andreas Kjaer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-03       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.